Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc. (VDI) ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
August 9, 2017 — HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical ...
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted the ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
August 9, 2017 — Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for ...
August 4, 2017 — In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing ...
August 3, 2017 — Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
The current generation of hemodynamic monitoring systems can help catheterization labs electronically document the ...
Aug. 3, 2017 — 4C Medical Technologies Inc. minimally invasive therapies for structural heart disease said its ...
Aug. 1, 2017 — LimFlow SA announced publication of positive results from the pilot study of the LimFlow Percutaneous ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Aug. 1, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology ...
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be ...
July 26, 2017 — The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
July 26, 2017 — Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the Knee ...
July 17, 2017 — LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow ...
July 14, 2017 — Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational ...
August 15, 2017